欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2011, Vol. 16 ›› Issue (1): 18-21.

• 基础研究 • 上一篇    下一篇

ZK-1注射液抗大鼠肝纤维化作用的实验研究

罗胜勇, 叶寿山, 马征, 李心伟, 贾德云, 倪光玉   

  1. 安徽省医学科学研究院药理毒理研究所,合肥 230061,安徽
  • 收稿日期:2010-11-19 修回日期:2010-12-19 发布日期:2020-09-16
  • 作者简介:罗胜勇,男,硕士研究生,助理研究员,研究方向:心脑血管药理。Tel: 13855137256 E-mail: lsy770728@126.com

Experimental studies of glutathione compound injection on anti-hepatic fibrosis in rats

LUO Sheng-yong,YE Shou-shan, MA Zheng, LI Xin-wei, JIA De-yun, NI Guang-yu   

  1. 1Department of Pharmacology and Toxicology, Anhui Provincial Institute of Medical Science, Hefei 230061, Anhui, China
  • Received:2010-11-19 Revised:2010-12-19 Published:2020-09-16

摘要: 目的: 观察ZK-1注射液对N,N-二甲基亚硝胺诱导大鼠肝纤维化形成的抑制作用。方法: 采用N,N-二甲基亚硝胺建立大鼠肝纤维化模型,血生化分析仪检测大鼠肝功能,酶联免疫吸附(ELISA)法测血清中透明质酸(HA)、转化生长因子β-1(TGFβ-1)含量,测定组织中羟脯氨酸(HYP)含量,并行肝脏组织病理学检查。结果: 与模型组比较,ZK-1注射液可明显降低大鼠谷草、谷丙转氨酶水平,明显提高血清总蛋白和白蛋白含量;明显降低血清HA、TGFβ-1含量和肝组织中HYP的水平。组织病理学检查显示,对肝组织纤维化病变有一定程度的改善作用。结论: ZK-1注射液对N,N-二甲基亚硝胺诱导大鼠肝纤维化形成具有一定的抑制作用,其机制可能与抑制TGFβ-1产生有关。

关键词: N,N-二甲基亚硝胺, 透明质酸, 羟脯氨酸, 转化生长因子β-1

Abstract: AIM: To investigate the inhibitory action of glutathione compound injection on dimethylnitrosamine-induced hepatic fibrosis in rats.METHODS: The hepatic fibrosis model in rats were established by injection of dimethylnitrosamin.The liver function, levels of hyaluronic acid(HA),hepatic hydroxyproline(HYP) , transforming growth factor β-1(TGFβ-1) and the pathological change were detected.RESULTS: Compared with model group, glutathione compound injection could markedly improve the liver function, significantly decreased the levels of HA, HYP and TGFβ-1, the pathological changes could also be alleviated.CONCLUSION: Glutathione compound injection has protective effect against hepatic fibrosis ,the possible mechanism might be related to decreasing the level of TGFβ-1.

Key words: Dimethylnitrosamin, Hyaluronic acid, Hepatic hydroxyproline, Transforming growth factor β-1  ,  ,  ,  ,  

中图分类号: